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Abstract
IMPORTANCE Conflicting evidence and large practice variation are present in the surgical treatment
of degenerative spondylolisthesis. More than 90% of surgical procedures in the United States
include instrumented fusion compared with 50% or less in other countries.
OBJECTIVE To evaluate whether the effectiveness of microdecompression alone is noninferior to
decompression with instrumented fusion in a real-world setting.
DESIGN, SETTING, AND PARTICIPANTS This multicenter comparative effectiveness study with a
noninferiority design assessed prospective data from the Norwegian Registry for Spine Surgery. From
September 19, 2007, to December 21, 2015, 1376 patients at 35 Norwegian orthopedic and
neurosurgical departments underwent surgery for lumbar spinal stenosis with degenerative
spondylolisthesis without scoliosis. After excluding patients undergoing laminectomy alone, fusion
without instrumentation, or surgery in more than 2 levels and those with a former operation at the
index level, 794 patients were included in the analyses, regardless of missing or incomplete follow-up
data, before propensity score matching. Data were analyzed from March 20 to October 30, 2018.
EXPOSURES Microdecompression alone or decompression with instrumented fusion.
MAIN OUTCOMES AND MEASURES A reduction from baseline of 30% or greater in the Oswestry
Disability Index at 12-month follow-up.
RESULTS After propensity score matching, 570 patients (413 female [72%]; mean [SD] age, 64.7
[9.5] years) were included for comparison, with 285 undergoing microdecompression (mean [SD]
age, 64.6 [9.8] years; 205 female [72%]) and 285 undergoing decompression with instrumented
fusion (mean [SD] age, 64.8 [9.2] years; 208 female [73%]). The proportion of each type of
procedure varied between departments. However, changes in outcome scores varied within patients
but not between departments. The proportion of patients with improvement in the Oswestry
Disability Index of at least 30% was 150 of 219 (68%) in the microdecompression group and 155 of
215 (72%) in the instrumentation group. The 95% CI (–12% to 5%) for the difference of −4% was
above the predefined margin of noninferiority (–15%). Microdecompression alone was associated
with shorter operation time (mean [SD], 89 [44] vs 180 [65] minutes; P < .001) and shorter hospital
stay (mean [SD], 2.5 [2.4] vs 6.4 [3.0] days; P < .001).
CONCLUSIONS AND RELEVANCE Among patients with degenerative spondylolisthesis, the clinical
effectiveness of microdecompression alone was noninferior to that of decompression with
instrumented fusion. Microdecompression alone was also associated with shorter durations of
(continued)
Key Points
Question How do outcomes compare
between microdecompression and
decompression with instrumented
fusion for patients undergoing surgery
for degenerative spondylolisthesis?
Findings In this comparative
effectiveness study including 285 pairs
of propensity score–matched patients,
150 of 219 patients (68%) in the
microdecompression group and 155 of
215 patients (72%) in the instrumented
fusion group achieved an improvement
in Oswestry Disability Index of at least
30%, a clinically meaningful noninferior
difference. Microdecompression was
associated with shorter operation time
and shorter length of hospital stay.
Meaning The findings suggest that
microdecompression alone should be
considered as an option for most
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Abstract (continued)
surgery and hospital stay, supporting the suggestion that the less invasive procedure should be
considered for most patients.
JAMA Network Open. 2020;3(9):e2015015. doi:10.1001/jamanetworkopen.2020.15015
Introduction
Degenerative spondylolisthesis is a forward slip of one vertebra relative to the vertebra below,
occurring in a spondylotic and narrowed spinal segment (ie, lumbar spinal stenosis).1 Typical
symptoms are low back pain and radiating pain into the buttocks and the legs, especially when
standing and walking. The standard surgical procedure has been to decompress the stenosis.2 In the
early 1990s, 2 landmark studies3,4 recommended additional fusion surgery. In the following decades,
the rate and complexity of fusion procedures increased dramatically.5,6 The fusion rate in the United
States more than doubled from 2005 to 2014, and degenerative spondylolisthesis accounted for
most fusions.7 In 2015, the hospital costs for elective lumbar degenerative fusions exceeded $10
billion, the highest aggregate costs of any surgical procedure in the United States.8 Adding
instrumented fusion to decompression has been supported by 1 randomized clinical trial (RCT)9 and
clinical guidelines and reviews.10-13 Another RCT,14 registry studies,15,16 and systematic reviews17,18
have recommended decompression alone.
The role of fusion surgery is controversial,19-21 and a large surgical practice variation between
hospitals is reported. In 2011 to 2013, approximately 50% of patients with degenerative
spondylolisthesis in Norway and Sweden underwent fusion procedures22 compared with 90% to
95% in other countries.6,7,22,23 Industrial boosting with differences in industrial encouragement and
lucrative financial reimbursement might explain some of the differences in practice.24,25
Only a few small-sample studies26-29 have evaluated the performance of less invasive methods
of decompression alone, preserving potentially stabilizing structures of the spine. In this study from
the Norwegian Registry for Spine Surgery (NORSpine), we hypothesized that in real-world daily
clinical practice, microdecompression alone works as well as decompression with
instrumented fusion.
Methods
Study Setting, Data Collection, and Patient Selection
The reporting and interpretation of this comparative effectiveness study followed the Strengthening
the Reporting of Observational Studies in Epidemiology (STROBE)30 recommendations and the
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) reporting guideline
for cohort studies.31 Relative effectiveness was studied using prospectively collected data from
NORSpine, a national comprehensive registry for quality control and research. According to NORSpine’s
annual report for 2015, the coverage rate for lumbar spine surgery was 93% at the hospital level and
63% at the individual level. The registry receives no funding from industry. At hospital admission
(baseline), the patients completed questionnaires, which included patient-reported outcome measures
and questions about demographics and lifestyle. The surgeons recorded surgical parameters such as
diagnosis, treatment, and occurrence of complications. At the 3- and 12-month follow-up, NORSpine’s
central unit sent questionnaires by mail to the patients without the involvement of the surgical units.
Written informed consent was obtained from the participants preoperatively, and the Norwegian
Committee for Medical and Health Research Ethics Central approved the study.
A total of 1376 patients undergoing surgical procedures for lumbar spinal stenosis with
degenerative spondylolisthesis from September 19, 2007, to December 21, 2015, at 35 orthopedic
and neurosurgical departments were screened for eligibility. Patients were excluded if they had
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undergone a previous procedure at the index level(s), a procedure in more than 2 levels, or a
procedure with an interspinous device or with an anterior approach. Patients were included
regardless of missing or incomplete follow-up data.
The primary and secondary outcomes, the criterion for noninferiority, and the statistical
methods were defined before statistical analysis.32 Data were analyzed from March 20 to October
30, 2018.
Treatment Groups
Patients who underwent microdecompression alone had preservation of the midline (ie, the spinous
process and the interspinous ligaments), and one of the following techniques was used: (1) unilateral
laminotomy, (2) bilateral laminotomy, or (3) unilateral laminotomy and crossover decompression.
Magnifying devices (microscopes or loupes) were used. Patients who underwent instrumented
fusion had a decompression with or without preservation of the midline structures and with or
without visual enhancement and additional posterior pedicle screw instrumentation with or without
an intervertebral cage.
Outcome Measures
The Oswestry Disability Index (ODI), version 2.033,34 is a pain-related disability score of 10 items
ranging from 0 (no impairment) to 100 (maximum impairment). The primary outcome was a
reduction from baseline of 30% or greater at the 12-month follow-up (ie, a clinically important
improvement).35,36 A patient achieving this amount of improvement was defined as a responder.
Secondary outcome measures included the following.
1. The mean change scores and the mean 12-month follow-up scores for the ODI and the Numeric
Rating Scale (NRS), which ranges from 0 (no pain) to 10 (worst pain imaginable) for leg pain and
for back pain experienced in the last week;
2. The Global Perceived Effect instrument37 with 7 response alternatives, including completely
recovered, much improved, slightly improved, unchanged, slightly worse, much worse, and worse
than ever, that were trichotomized into substantially improved (completely recovered and much
improved), little or no change (slightly improved, unchanged, and slightly worse), and
substantially deteriorated (much worse and worse than ever);
3. Duration of surgery and hospital stay;
4. The rate of perioperative complications and adverse events registered on the surgeon form; and
5. The rate of complications and adverse events reported by the patients at the 3-month follow-up.
Statistical Analysis
To make the distribution of observed baseline patient characteristics in the 2 treatment groups as
similar as possible, propensity score matching was performed.38 A propensity score, derived from a
logistic regression model, is defined as a patient’s baseline probability for receiving decompression
plus instrumented fusion, conditional on prespecified plausible confounders (age, sex, American
Society of Anesthesiologists grade, body mass index, smoking, ODI, NRS leg pain score, NRS back
pain score, the European Quality of Life–5 Dimensions questionnaire, the presence of foraminal
stenosis, degenerative disc disease, predominating back pain, number of levels undergoing surgery,
and neurological palsy). We used the technique of 1:1 matching without replacement, forming paired
cases of microdecompression alone and decompression plus fusion, which had a difference in
propensity scores of less than 0.2 in logit of the standard deviation.38
The null hypothesis was that the proportion of patients with a clinically important improvement
(the responder rate) was at least 15 percentage points lower in the microdecompression group than
in the fusion group. The null hypothesis was tested by forming a 2-sided 95% CI for the between-
group difference in responder rate and would be rejected if the lower bound of the CI was greater
than −15%. A noninferiority margin of −15% was assumed to reflect the advantage of performing
microdecompression alone instead of the more extensive and expensive instrumentation.39,40 This
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margin is consistent with analysis in other relevant studies.39-41 The margin corresponds to a number
needed to treat of 7 patients (100/15 [6.67]),42 that is, if 7 patients or more need instrumented fusion
to achieve 1 additional responder, the cheaper, safer, and less comprehensive method of
microdecompression alone should be considered good enough (ie, noninferior).
Level and change in the ODI and NRS leg and back pain scores were estimated by multisample
latent growth curve (LGC) models, with full information maximum likelihood43 under the assumption
of missing at random. Owing to nonlinearity, the models were specified as a latent difference score
model, including changes from baseline to 3 months, from 3 to 12 months, and the 12-month
follow-up (intercept level). The proportion of each type of procedure varied between departments.
Patient data were nested within hospital departments and could show clustering effects within units.
However, multilevel analyses showed low interclass correlation values for the ODI of 0.023 (baseline)
to 0.042 (12 months), for NRS leg pain of 0.026 (baseline) to 0.067 (3 months), and for NRS back
pain of 0.013 (3 months) to 0.066 (12 months). The estimated design effect, taking cluster size and
interclass correlation into account, showed the highest value to be 2.00 (leg pain at 3 months), which
is in the borderline for nonignorable clustering.44 However, multilevel models including random
slope variance at the hospital department level showed no department differences in change scores
in the 2 intervals.
The intercept variance was found to be statistically significant for NRS leg pain (σ2 = 0.49;
P = .03) but not for the ODI (σ2 = 13.52; P = .13) or NRS back pain (σ2 = 0.12; P = .10). Due to this level
of clustering and the focus on observations within patients, single-level LGC models were estimated
with robust standard errors corrected for clustering with the maximum likelihood robust.44
For secondary outcomes, comparisons of treatment groups and corresponding estimates of P
values and 95% CI were based on 2-sided tests for superiority. SPSS, version 24 (IBM Corporation)
was used for descriptive statistics, analyses of continuous variables with 2-sided t tests or Mann-
Whitney tests depending on the distribution of data, analyses of binary variables with Fisher mid-P
value and Newcombe hybrid score CIs,45 and propensity score matching. The LGC analysis was
performed with Mplus 8 (Muthén & Muthén).46 P < .05 indicated statistical significance.
Missing Data
A loss to follow-up of about 20% was anticipated.15,47 A previous study from NORSpine showed
similar clinical outcome measures for compliers and noncompliers,48 so longitudinal outcome
variables were analyzed under the assumption of missingness at random. An additional missing data
LGC analysis under the missing data at random assumption was performed for the matched cohort.
Multiple imputation49 was used with baseline patient characteristics; several clinical, surgical, and
radiological parameters; and outcome variables at baseline and follow-up to generate 70 data sets
with complete follow-up scores for the ODI and NRS leg pain and back pain. This procedure is
recommended if missing data at random may only be partly assumed.50 Including such covariates
may increase the probability for missing data at random and reduce the probability of missingness
not at random.50
Sample Size
For the primary outcome, choosing a 15% noninferiority margin, a type 1 error of 0.05, and power of
0.90 gave a total sample size of 394. An expected 75% follow-up15 rate at 12 months required 263
patients in each group.51
Results
Of 794 patients who met study eligible criteria, 476 (60%) underwent microdecompression alone
(mean [SD] age, 67.5 [9.9] years; 307 female [64%]), and 318 (40%) underwent decompression plus
instrumented fusion (mean [SD] age, 63.5 [10.0] years; 240 female [76%]). After propensity score
matching, 570 patients (413 female [72%] and 157 male [28%]; mean [SD] age, 64.7 [9.5] years)
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remained, of whom 285 patients underwent microdecompression alone (mean [SD] age, 64.6 [9.8]
years; 205 female [72%] and 80 male [28%]), and 285 underwent decompression and
instrumentation (mean [SD] age, 64.8 [9.2] years; 208 female [73%] and 77 male [27%]). Figure 1
shows the enrollment of participants. Baseline parameters are given in Table 1, and surgical
parameters are shown in eTable 1 in the Supplement.
Unmatched Cohort
Follow-up scores of the ODI and NRS leg pain and back pain are shown in eTable 2 in the Supplement.
The proportion of patients with a clinically important improvement of the ODI at 12 months was 243
of 343 (71%) in the microdecompression group and 163 of 232 (70%) in the instrumentation group
(difference, 1%; 95 CI, –7% to 8%) (Figure 2).
Propensity Score–Matched Cohort
Table 1 demonstrates that propensity score matching created similar groups with respect to the
distribution of observed baseline parameters. The follow-up rate was 423 of 570 (74%) at 3 months
and 438 of 570 (77%) at 12 months (Figure 1), and 479 of 570 participants (84%) had at least 1
follow-up registration.
Figure 1. Study Flowchart
9020 Patients registered with spinal stenosis 
1372 Patients with a concomitant degenerative spondylolisthesis 
794 Unmatched cohort 
1068 Patients with a primary operation for degenerative
spondylolisthesis 
7648 Excluded patients without spondylolisthesis
304 Excluded owing to eligibility criteria
166 Prior operation at index level 
54 >2 Levels operated 
4 Surgery with ALIF or X-stop
80 Degenerative scoliosis
274 Excluded owing to eligibility criteria 
157 Laminectomy alone
117 Fusion without instrumentation
191 Excluded owing to matching
476 Surgery with microdecompression alone  
285 Fulfilled the baseline form 
214 Fulfilled the 3-mo form 
71 Lost to follow-up 
220 Fulfilled the 12-mo form 
65 Lost to follow-up 
33 Excluded owing to matching
318 Surgery with microdecompression and
instrumented fusion  
285 Fulfilled the baseline form 
209 Fulfilled the 3-mo form 
76 Lost to follow-up 
218 Fulfilled the 12-mo form 
67 Lost to follow-up ALIF indicates anterior lumbar interbody fusion.
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Primary Outcome
The proportion of patients with a clinically important improvement in the ODI at the 12-month
follow-up was 150 of 219 (68%) in the microdecompression group and 155 of 215 (72%) in the
instrumented fusion group. The lower bound of the 95% CI (–12% to 5%) for the between-group
difference of −4% did not cross the −15% limit of noninferiority (Figure 2). An absolute difference of
4% corresponds to a number needed to treat of 25 patients (95% CI, 8 to ).
Secondary Outcomes
Table 2 shows the mean change from baseline to 3 months, the mean change from 3 to 12 months,
and the mean 12-month follow-up scores for the ODI and NRS leg and back pain. At 12 months, we
observed no statistically significant difference in mean ODI scores between microdecompression
alone and instrumented fusion (mean [SD], 22.2 [18.2] and 20.5 [17.7], respectively; mean difference
1.7 [95% CI, –2.4 to 5.8]; P = .42). At 12 months, the microdecompression group had statistically
significantly higher scores for NRS leg pain (mean [SD], 3.5 [3.0] vs 2.7 [2.9]; mean difference, 0.8
[95% CI, 0.1-1.4]; P = .02) and NRS back pain (mean [SD], 3.8 [2.9] vs 3.3 [2.6]; mean difference, 0.6
[95% CI, 0.01-1.1]; P = .04) compared with the instrumented fusion group.
According to the Global Perceived Effect at the 12-month follow-up (eTable 3 in the
Supplement), the rate of substantial improvement (145 of 218 [67%] for microdecompression and
154 of 217 [71%] for fusion; difference, –4% [95% CI, –13% to 4%]; P = .32) and the rate of substantial
deterioration (9 of 218 [4%] for microdecompression and 8 of 217 [4%] for fusion; difference, 0
[95% CI, –3% to 4%]; P = .81) did not differ between groups.
The duration of surgery (mean [SD], 89 [44] vs 180 [65] minutes; difference, –91 [95% CI, –100
to –81] minutes; P < .001) and the length of hospital stay (mean [SD], 2.5 [2.4] vs 6.4 [3.0] days;
difference, −3.9 [95% CI, –4.4 to –3.4] days; P < .001) was statistically significantly shorter for
Table 1. Baseline Data for the Unmatched and Matched Cohorts
Characteristic












(n = 285) P value
Age, mean (SD), ya 67.5 (9.9) 63.5 (10.0) <.001 64.6 (9.8) 64.8 (9.2) .79
Female sex, No./total No. (%)a 307/476 (65) 240/318 (75) <.001 205/285 (72) 208/285 (73) .78
≥3 y of Education, No./total No. (%)a 149/464 (32) 104/314 (33) .77 98/280 (35) 93/281 (33) .64
ASA score, mean (SD)b,c 2.10 (0.58) 1.97 (0.52) <.001 2.01 (0.58) 2.00 (0.51) .94
BMI, mean (SD)a 26.9 (4.4) 27.1 (5.2) .65 27.1 (4.4) 26.7 (4.6) .41
Smoker, No./total No. (%)a 81/474 (17) 56/315 (18) .80 57/283 (20) 51/282 (18) .54
Anxiety or depression, No./total No. (%)a,d 165/463 (36) 131/303 (43) .04 112/280 (40) 109/271 (40) .96
Disc degeneration, No./total No. (%)c 103/476 (22) 52/318 (16) .07 47/285 (16) 49/285 (17) .82
Foraminal stenosis, No./total No. (%)c 40/476 (8) 35/318 (11) .22 28/285 (10) 27/285 (9) .89
Leg pain >1 y, No./total No. (%)a 303/438 (69) 211/295 (72) .50 194/266 (73) 184/265 (69) .37
Back pain >1 y, No./total No. (%)a 348/446 (78) 254/303 (84) .50 224/268 (84) 222/270 (82) .68
Use of analgesics, No./total No. (%)a 369/469 (79) 272/316 (86) .009 238/282 (84) 239/283 (84) .99
Neurological palsy, No./total No. (%)c 30/476 (6) 14/318 (4) .25 14/285 (5) 13/285 (5) .84
Predominant back pain, No./total No. (%)a 28/407 (7) 25/264 (9) .23 23/241 (10) 22/237 (9) .92
ODI, mean (SD)a,e 40.2 (15.4) 41.4 (14.4) .30 41.3 (15.6) 40.8 (14.1) .69
NRS leg pain, mean (SD)a,f 6.9 (2.1) 6.6 (2.1) .12 6.7 (2.1) 6.7 (2.0) .97
NRS back pain, mean (SD)a,f 6.7 (2.1) 6.8 (1.9) .81 6.7 (2.0) 6.8 (1.9) .70
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index
(calculated as weight in kilograms divided by height in meters squared); NRS, Numeric
Rating Scale; ODI, Oswestry Disability Index.
a Data collected from patient forms.
b Scores range from 1 (no presence of disease) to 4 (life-threatening disease).
c Data collected from surgeon forms.
d Includes patients who replied “moderately anxious or depressed” or “extremely
anxious or depressed” according to the European Quality of Life–5 Dimensions
questionnaire.
e Scores range from 0 to 100, with higher scores indicating more disability.
f Scores range from 0 to 10, with higher scores indicating more pain.
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microdecompression alone than for instrumented fusion (Table 3). The microdecompression group
had fewer surgeon-reported perioperative complications than the fusion group (7 of 285 [2%] vs 24
of 285 [8%]; difference, –6% [95% CI, –10% to –2%]; P = .003). In both groups, the most common
complication was a dural tear (5 of 285 [2%] and 16 of 285 [6%]; difference, –4% [95% CI, –7% to
0%]; P = .02). Patients undergoing microdecompression alone reported a statistically significantly
higher incidence of superficial wound infection than the fusion group during the first 3 months
postoperatively (16 of 209 [8%] and 5 of 174 [3%]; difference, 5% [95% CI, 0 to 10%]; P = .04).
Other registered complications are listed in Table 3.
eTable 4 in the Supplement shows 12-month follow-up results for the LGC models subsequent
to multiple imputation of missing data. At 12 months, there were no differences in the ODI and NRS
back pain between the groups, whereas NRS leg pain was statistically significantly higher for the
microdecompression group than for the instrumented fusion group (mean [SD], 3.5 [3.0] and 2.8
[3.0]; mean difference, 0.7 [95% CI, 0.1-1.3]; P = .03).
Discussion
Microdecompression alone was noninferior to decompression plus instrumented fusion. The result
of the primary outcome was supported by the patients’ global perceived effects and by analyses of
the mean ODI scores both before and after imputation of missing data. Furthermore,
microdecompression alone was associated with considerably shorter duration of surgery and
hospital stay and somewhat fewer surgeon-reported perioperative complications. Patients treated
Figure 2. Differences Between Treatment Groups in Primary Outcome
–15 0 1510–5 5








Unmatched 1.0  (–7.0 to 8.0)
Matched –4.0  (–12.0 to 5.0)
Data show the proportion of patients with reduction from baseline of 30% or
greater in the Oswestry Disability Index at the 12-month follow-up. Dashed line
indicates the predefined margin of noninferiority.
Table 2. Patient-Reported Outcomes in the Propensity Score–Matched Cohort, Estimated
With Latent Growth Curve Models
Variable






(n = 285) Mean (95% CI) P value
ODIc
Change 0 to 3 mo –20.0 (17.6) –19.4 (18.4) –0.6 (–4.5 to 3.3) .77
Change >3 to 12 mo 0.9 (12.7) –0.9 (14.4) 1.8 (–1.3 to 4.8) .26
12-mo Follow-up 22.2 (18.2) 20.5 (17.7) 1.7 (–2.4 to 5.8) .42
NRS leg paind
Change 0 to 3 mo –3.7 (3.2) –4.4 (3.3) 0.7 (0.2 to 1.2) .01
Change >3 to 12 mo 0.5 (2.6) 0.4 (2.6) 0.1 (–0.4 to 0.6) .69
12-mo Follow-up 3.5 (3.0) 2.7 (2.9) 0.8 (0.1 to 1.4) .02
NRS back paind
Change 0 to 3 mo –3.3 (2.9) –3.6 (2.9) 0.3 (–0.3 to 0.9) .33
Change >3 to 12 mo 0.4 (2.5) 0.06 (2.6) 0.3 (–0.2 to 0.9) .22
12-mo Follow-up 3.8 (2.9) 3.3 (2.6) 0.6 (0.01 to 1.1) .04
Abbreviations: NRS, Numeric Rating Scale; ODI,
Oswestry Disability Index.
a Estimated with multisample latent growth
curve models.
b Calculated as the score for microdecompression
alone minus the score for decompression and
instrumented fusion with 95% CIs and 2-sided tests
for superiority.
c Scores range from 0 to 100, with higher scores
indicating more disability.
d Scores range from 0 to 10, with higher scores
indicating more pain.
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with instrumented fusion had slightly less leg and back pain and fewer patient-reported superficial
wound infections.
Other unmatched observational studies26-29 have found nondifferent outcomes between
microdecompression alone and decompression plus instrumented fusion. Unlike our study, these
studies did not reveal any between-group differences in outcome scores for leg or back pain.
Following 2 simultaneously published RCTs,9,14 the role of fusion has been debated.19-21,52,53 In
the RCT by Ghogawala et al,9 51 of 71 patients underwent procedures performed by 1 surgeon.
Decompression alone resulted in less improvement in the physical component of the generic 36-Item
Short Form Health Survey than instrumented fusion 2 years after surgery. The improvement in ODI
scores was not statistically significantly different between the groups. The more pragmatic
multicenter RCT by Försth et al14 (n = 135) used the ODI as the primary outcome measurement and
revealed baseline scores as well as follow-up scores in accordance with our results.
Randomized clinical trials are the criterion standard for studying treatment efficacy, but their
generalizability has been questioned owing to strictly recruited patients and clinicians and enforced
treatment allocation.54 This study was designed to reflect real-world relative effectiveness between
carefully matched groups. The aim was to study patients recruited in daily clinical practice at several
different hospitals and the treatments chosen according to surgeon and patient preferences.54,55
Our study provides knowledge about how treatments work in the more pragmatic delivery of
health care.54,56,57
Based on the present study as well as previous pragmatic studies14,16 and considering the large
clinical practice variation,6,22,23 the high rate of instrumented fusion seems unreasonable. In
accordance with a priori expectations and former studies,23,58 our findings of shorter operation times
and hospital stays indicate that a microdecompression alone is associated with acceptable clinical
results at lower costs. Although instrumented fusion was associated with somewhat more pain
reduction, the high number needed to achieve 1 additional responder and the somewhat higher
perioperative complication rate showed disadvantages of instrumentation. Altogether, we consider
the noninferior clinical effectiveness and the potential health-economic benefits of
microdecompression alone to surpass the procedure’s potential inferiority.







(n = 285) Difference (95% CI)a P valueb
Operation time, mean (SD), minc 89 (44) 180 (65) –91 (–100 to –81) <.001
Duration of hospital stay,
mean (SD), dc
2.5 (2.4) 6.4 (3.0) –3.9 (–4.4 to –3.4) <.001
Perioperative complications,
No./total No. (%)d
7/285 (2) 24/285 (8) –6 (–10 to –2) .003
Dural tears 5/285 (2) 16/285 (6) –4 (–7 to 0) .02
Nerve root lesion 0 1/285 (0.4) NC NC
Operation on wrong
side/level
1/285 (0.4) 1/285 (0.4) NC NC
Blood transfusion 1/285 (0.4) 1/285 (0.4) NC NC
Misplaced implants NA 2/285 (1) NC NC
Cardiac complication 1/285 (0.4) 1/285 (0.4) NC NC
Patient-reported complications
during the first 3 mo, No./total
No. (%)e
Superficial wound infection 16/209 (8) 5/174 (3) 5 (0 to 10) .04
Deep wound infection 3/207 (1) 0/174 NC NC
Deep venous thrombosis 1/207 (0.5) 0/174 NC NC
Lung thrombosis 1/207 (0.5) 2/174 (1) NC NC
Pneumonia 5/207 (2) 2/174 (1) NC NC
Urinary tract infection 17/207 (8) 14/174 (8) 0 (–5 to 6) .96
Abbreviations: NA, not applicable; NC, not computed.
a Calculated as microdecompression alone minus
decompression and fusion with 95% CI.
b Calculated using 2-sided tests for superiority.
c Collected during hospital stay.
d Collected from surgeon forms.
e Collected from patient forms.
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However, this study does not provide evidence that microdecompression alone should be the
preferred method for all patients. Adding fusion to decompression may still be a good treatment
option for subgroups. Owing to a lack of evidence for defining such subgroups, future research
should endeavor to identify variables associated with the best treatment for each individual.39
Limitations
The diagnoses of spinal stenosis and degenerative spondylolisthesis are based on the surgeons’
evaluation of radiographs, the radiological descriptions, and clinical signs and symptoms. We have
not retrospectively checked whether all established diagnostic criteria59 were fulfilled. Incorrect
diagnoses may therefore have been undetected. Furthermore, data on reoperations and data
beyond the 12-month follow-up are lacking. Some studies have found lower reoperation rates when
a decompression has been supported by fusion,9,60 whereas other studies have demonstrated
similar14 and even higher27 reoperation rates after an additional fusion. For a mixed population
undergoing spinal surgical procedures, the clinical outcomes at the 12-month follow-up seem to be
the same as the 2-year outcomes61,62 and stable even at the 5-year follow-up.26,63,64
Finally, it is important to recognize that, unlike an RCT, this study was not able to detect
treatment-related differences in efficacy. Although the propensity score matching equalized the
baseline scores regarding the observed parameters, the distribution of unobserved parameters (eg,
radiological parameters and potential differences associated with patients’ expectations owing to
given information) might have been unbalanced. A risk of residual bias does therefore still exist.
Conclusions
This study found that microdecompression alone seems to be not appreciably worse than
decompression and instrumented fusion for treatment of degenerative spondylolisthesis. We would
carefully suggest the less extensive and less expensive treatment as the primary surgical choice for
most patients with lumbar degenerative spondylolisthesis.
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